Structured evidence table for Beta Glucan Stress Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Beta Glucan Stress Randomized Trial | By interacting with innate pattern recognition receptors (PRRs), including Dectin-1 and Toll-like receptors (TLRs), expressed on gut-associated lymphoid tissue (GALT) and immune cells, β-1,3-glucans regulate both innate and adaptive immune responses [,]. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Stress Randomized Trial | Table 2 A summary of β-glucans derived from different fungal sources and their associated therapeutic properties is provided in. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Stress Randomized Trial | Although multiple receptor systems are involved, the overall framework is conserved and relies on the detection of pathogen-associated molecular patterns (PAMPs) by PRR families, including Dectin-1, TLRs, complement receptor 3 (CR3), lactosylceramide (LacCer), and scavenger receptors (SRs). | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Stress Randomized Trial | 1 2 2 Glucans are polysaccharides composed entirely of glucose monomers and are generally classified into three structural categories: α-glucans, β-glucans, and mixed α, β-glucans [,]. | 4 | Samiksha Fnu (2026) | Fungal β-1,3-glucans: Cell Wall Constituents That Promote Gut Health Through Innate Immune Modulation |
| Beta Glucan Stress Randomized Trial | However, most clinical trials to date have focused on moderate to high doses of YBG (≥250 mg/day) over short to moderate durations (ranging from 7 days to 3 months).Evidence on the efficacy, tolerability, and sustainability of low-dose supplementation remains scarce, despite its practical advantages for daily, long-term use. | 4 | Habibullah Nur Nadia Mohamad (2026) | Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults |
| Beta Glucan Stress Randomized Trial | The modest declines across all groups suggest a trend toward improved vitality but no differential treatment effect. | 4 | Habibullah Nur Nadia Mohamad (2026) | Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults |
| Beta Glucan Stress Randomized Trial | For (A–F) and (H), lower scores indicate reduced negative mood states; for (G) (Vigor), higher scores indicate increased energy and vitality. | 4 | Habibullah Nur Nadia Mohamad (2026) | Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults |
| Beta Glucan Stress Randomized Trial | To address this gap, the present randomized, double-blind, placebo-controlled trial investigated the effects of 12-week supplementation with low-dose (120 mg) and moderate-dose (204 mg) YBG among moderately stressed adults. | 4 | Habibullah Nur Nadia Mohamad (2026) | Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults |
Source documents